Featured News

Millman Lab receives funding to improve engraftment of stem cells through genetic engineering 

In January, Jeffrey Millman, PhD was awarded funding of $450,000 from JDRF for his lab’s project titled “Genetic Engineering to Improve Engraftment of Stem Cell-Derived Islets.”   

Transplantation of new insulin-producing cells into the patients could be a functional cure for type 1 diabetes. We have developed a method for creating these cells in the lab using stem cells. However, most of these cells don’t survival after transplantation. Using this generous support from the JDRF, we will modify the cells using genetic engineering to make them better able to survive after transplantation to greatly improve their therapeutic benefit.

Jeffrey Millman, PhD

To learn more about Millman Lab and the work they’re doing, visit here